# EDGAR Filing Document

**Accession Number:** 0000886206
**File Stem:** 0000886206-23-000005
**Filing Date:** 2023-1
**Character Count:** 89867
**Document Hash:** 9d9d24eca9ba4d389cbae6833bf213f8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000886206-23-000005.hdr.sgml**: 20230109

**ACCESSION NUMBER**: 0000886206-23-000005

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 48

**CONFORMED PERIOD OF REPORT**: 20221130

**FILED AS OF DATE**: 20230109

**DATE AS OF CHANGE**: 20230109

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FRANKLIN COVEY CO
- **CENTRAL INDEX KEY:** 0000886206
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT SERVICES [8741]
- **IRS NUMBER:** 870401551
- **STATE OF INCORPORATION:** UT
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11107
- **FILM NUMBER:** 23518493

**BUSINESS ADDRESS:**
- **STREET 1:** 2200 W PARKWAY BLVD
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84119-2331
- **BUSINESS PHONE:** 8018175030

**MAIL ADDRESS:**
- **STREET 1:** 2200 W PARKWAY BLVD
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84119

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FRANKLIN QUEST CO
- **DATE OF NAME CHANGE:** 19940218

?xml version="1.0" encoding="utf-8"? fc-20221130x10q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

# **FORM 10-Q** 
(Mark One)

[X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2022

[ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-11107

![Logo Description automatically generated](fc-20221130x10qg001.jpg)

**FRANKLIN COVEY CO.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| Utah | 87-0401551 |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. employer identification no.) |
| 2200 West Parkway Boulevard | 84119-2099 |
| Salt Lake City, Utah | (Zip Code) |
| (Address of principal executive offices) |  |
| Registrant's telephone number, | (801) 817-1776 |
| Including area code |  |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| <u>Title of Each Class</u> | <u>Name of each exchange on which registered</u> |
| Common Stock, $.05 Par Value<br> FC | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ⬜

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ⬜

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large Accelerated Filer | ⬜ | Accelerated Filer | ☒ |
| Non-accelerated Filer | ⬜ | Smaller Reporting Company | ⬜ |
| Emerging Growth Company | ⬜ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ⬜

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ⬜ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of Common Stock as of the latest practicable date:

13,905,044 shares of Common Stock as of December 31, 2022

‎

------

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

<u>FRANKLIN COVEY CO.</u>

## <u>CONDENSED CONSOLIDATED BALANCE SHEETS</u> 
(in thousands, except per-share amounts)

---

| | | |
|:---|:---|:---|
|  | November 30, | August 31, |
|  | 2022 | 2022 |
|  | (unaudited) | (unaudited) |
| ASSETS |  |  |
| &nbsp;&nbsp;Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $58152 | $60517 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, less allowance for doubtful accounts of $4,427 and $4,492 | 57352 | 72561 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 3477 | 3527 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 17364 | 19278 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 136345 | 155883 |
| &nbsp;&nbsp;Property and equipment, net | 9465 | 9798 |
| &nbsp;&nbsp;Intangible assets, net | 43742 | 44833 |
| &nbsp;&nbsp;Goodwill | 31220 | 31220 |
| &nbsp;&nbsp;Deferred income tax assets | 4279 | 4686 |
| &nbsp;&nbsp;Other long-term assets | 12378 | 12735 |
|  | $**237429** | $**259155** |
| LIABILITIES AND SHAREHOLDERS' EQUITY |  |  |
| &nbsp;&nbsp;Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of notes payable | $5835 | $5835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of financing obligation | 3281 | 3199 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 6878 | 10864 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred subscription revenue | 74394 | 85543 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other deferred revenue | 13906 | 14150 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 23380 | 34205 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 127674 | 153796 |
| &nbsp;&nbsp;Notes payable, less current portion | 6045 | 7268 |
| &nbsp;&nbsp;Financing obligation, less current portion | 7105 | 7962 |
| &nbsp;&nbsp;Other liabilities | 6788 | 7116 |
| &nbsp;&nbsp;Deferred income tax liabilities | 199 | 199 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 147811 | 176341 |
| &nbsp;&nbsp;Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.05 par value; 40,000 shares authorized, 27,056 shares issued | 1353 | 1353  |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 222413 | 220246 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 86688 | 82021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (672) | (542) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock at cost, 13,165 shares and 13,203 shares | (220164) | (220264) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 89618 | 82814 |
|  | $**237429** | $**259155** |

---

See notes to condensed consolidated financial statements

‎

------

<u>FRANKLIN COVEY CO.</u>

## <u>CONDENSED CONSOLIDATED INCOME STATEMENTS AND STATEMENTS</u> 

## <u>OF COMPREHENSIVE INCOME</u> 
(in thousands, except per-share amounts)

---

| | | |
|:---|:---|:---|
|  | Quarter Ended | Quarter Ended |
|  | November 30, | November 30, |
|  | 2022 | 2021 |
|  | (unaudited) | (unaudited) |
| Net sales | $69369  | $61259  |
| Cost of sales | 16627  | 13661  |
| Gross profit | 52742  | 47598  |
| Selling, general, and administrative | 44012  | 39343  |
| Depreciation | 1246  | 1279  |
| Amortization | 1092  | 1431  |
| &nbsp;&nbsp;Income from operations | 6392  | 5545  |
| Interest income | 81  | 15  |
| Interest expense | (410) | (446) |
| &nbsp;&nbsp;Income before income taxes | 6063  | 5114  |
| Income tax provision | (1396) | (1302) |
| &nbsp;&nbsp;Net income | $**4667** | $**3812**  |
| Net income per share: |  |  |
| &nbsp;&nbsp;Basic | $0.34 | $0.27  |
| &nbsp;&nbsp;Diluted | 0.32 | 0.27  |
| Weighted average number of common shares: |  |  |
| &nbsp;&nbsp;Basic | 13877  | 14246  |
| &nbsp;&nbsp;Diluted | 14507  | 14312  |
| COMPREHENSIVE INCOME |  |  |
| Net income | $4667 | $3812  |
| Foreign currency translation adjustments, |  |  |
| &nbsp;&nbsp;net of income taxes of $0 and $0 | (130) | (144) |
| Comprehensive income | $**4537** | $**3668**  |

---

See notes to condensed consolidated financial statements

‎

------

<u>FRANKLIN COVEY CO.</u>

#### <u>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</u> 
(in thousands)

---

| | | |
|:---|:---|:---|
|  | Quarter Ended | Quarter Ended |
|  | November 30, | November 30, |
|  | 2022 | 2021 |
|  | (unaudited) | (unaudited) |
| CASH FLOWS FROM OPERATING ACTIVITIES |  |  |
| &nbsp;&nbsp;Net income | $4667 | $3812  |
| &nbsp;&nbsp;Adjustments to reconcile net income to net cash |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 2338 | 2710  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of capitalized curriculum costs | 843 | 789  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 2735 | 1649  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 393 | 679  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration liabilities | 7 | 28  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of right-of-use operating lease assets | 203 | 225  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities, net of effect of acquired business: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in accounts receivable, net | 15144 | 18829  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease (increase) in inventories | 38 | (92) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in prepaid expenses and other assets | 2306 | 196  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in accounts payable and accrued liabilities | (14098) | (9825) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in deferred revenue | (11501) | (8219) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease (increase) in income taxes payable | 31 | (47) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in other long-term liabilities | (89) | (570) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 3017 | 10164  |
| CASH FLOWS FROM INVESTING ACTIVITIES |  |  |
| &nbsp;&nbsp;Purchases of property and equipment | (1240) | (520) |
| &nbsp;&nbsp;Curriculum development costs | (974) | (243) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used for investing activities | (2214) | (763) |
| CASH FLOWS FROM FINANCING ACTIVITIES |  |  |
| &nbsp;&nbsp;Principal payments on notes payable | (1250) | (1250) |
| &nbsp;&nbsp;Principal payments on financing obligation | (774) | (698) |
| &nbsp;&nbsp;Purchases of common stock for treasury | (835) | (3488) |
| &nbsp;&nbsp;Payment of contingent consideration liabilities | (429) | (368) |
| &nbsp;&nbsp;Proceeds from sales of common stock held in treasury | 367 | 344  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used for financing activities | (2921) | (5460) |
| Effect of foreign currency exchange rates on cash and cash equivalents | (247) | (108) |
| Net increase in cash and cash equivalents | (2365) | 3833  |
| Cash and cash equivalents at the beginning of the period | 60517  | 47417  |
| Cash and cash equivalents at the end of the period | $**58152** | $**51250**  |
| Supplemental disclosure of cash flow information: |  |  |
| &nbsp;&nbsp;Cash paid for income taxes | $836 | $577  |
| &nbsp;&nbsp;Cash paid for interest | 372 | 410  |
| Non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;Purchases of property and equipment financed by accounts payable  | $213 | $238  |
| &nbsp;&nbsp;Acquisition of right-of-use operating lease assets for operating lease liabilities | 128 | 142  |

---

See notes to condensed consolidated financial statements

‎

------

<u>FRANKLIN COVEY CO.</u>

#### <u>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</u> 
(in thousands and unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  | Accumulated |  |  |
|  | Common | Common | Additional |  | Other | Treasury | Treasury |
|  | Stock | Stock | Paid-In | Retained | Comprehensive | Stock | Stock |
|  | Shares | Amount | Capital | Earnings | Loss | Shares | Amount |
| Balance at August 31, 2022 | 27056  | $1353  | $220246  | $82021  | $(542) | (13203) | $(220264) |
| Issuance of common stock from |  |  |  |  |  |  |  |
| &nbsp;&nbsp;treasury |  |  | (568) |  |  | 56  | 935  |
| Purchases of common shares |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;for treasury |  |  |  |  |  | (18) | (835) |
| Stock-based compensation |  |  | 2735  |  |  |  |  |
| Cumulative translation |  |  |  |  |  |  |  |
| &nbsp;&nbsp;adjustments |  |  |  |  | (130) |  |  |
| Net income |  |  |  | 4667  |  |  |  |
| Balance at November 30, 2022 | 27056  | $1353  | $222413  | $86688  | $(672) | (13165) | $(220164) |

---

<u>FRANKLIN COVEY CO.</u>

#### <u>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY –</u> 

#### <u>PRIOR YEAR</u> 
(in thousands and unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  | Accumulated |  |  |
|  | Common | Common | Additional |  | Other | Treasury | Treasury |
|  | Stock | Stock | Paid-In | Retained | Comprehensive | Stock | Stock |
|  | Shares | Amount | Capital | Earnings | Income | Shares | Amount |
| Balance at August 31, 2021 | 27056  | $1353  | $214888  | $63591  | $709  | (12889) | $(200678) |
| Issuance of common stock from |  |  |  |  |  |  |  |
| &nbsp;&nbsp;treasury |  |  | (3033) |  |  | 217  | 3378  |
| Purchases of common shares |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;for treasury |  |  |  |  |  | (85) | (3488) |
| Stock-based compensation |  |  | 1649  |  |  |  |  |
| Cumulative translation |  |  |  |  |  |  |  |
| &nbsp;&nbsp;adjustments |  |  |  |  | (144) |  |  |
| Net income |  |  |  | 3812  |  |  |  |
| Balance at November 30, 2021 | 27056  | $1353  | $213504  | $67403  | $565  | (12757) | $(200788) |

---

See notes to condensed consolidated financial statements

‎

------

<u>FRANKLIN COVEY CO.</u>

#### <u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u> 
(unaudited)

**NOTE 1 – BASIS OF PRESENTATION**

**General**

Franklin Covey Co. (hereafter referred to as us, we, our, or the Company) is a global company focused on organizational performance improvement. Our mission is to "enable greatness in people and organizations everywhere," and our global structure is designed to help individuals and organizations achieve sustained superior performance through changes in human behavior. We are fundamentally a content and solutions company, and we believe that our offerings and services create the connection between capabilities and results. We have a wide range of content delivery options, including: the All Access Pass (AAP) subscription, the *Leader in Me* membership, and other intellectual property licenses; digital online learning; on-site training; training led through certified facilitators; blended learning; and organization-wide transformational processes, including consulting and coaching. We believe our investments in digital delivery modalities over the past few years have enabled us to deliver our content to clients in a high-quality learning environment whether those clients are working remotely or in a centralized location. We believe that our clients are able to utilize our content to create cultures whose hallmarks are high-performing, collaborative individuals, led by effective, trust-building leaders who execute with excellence and deliver measurably improved results for all of their key stakeholders.

We have some of the best-known offerings in the training industry, including a suite of individual-effectiveness and leadership-development training content based on the best-selling books, *The 7 Habits of Highly Effective People*, *The Speed of Trust*, *The Leader in Me*, *The 4 Disciplines of Execution*, and *Multipliers*, and proprietary content in the areas of Leadership, Execution, Productivity, Educational Improvement, and Sales Performance. Our offerings are described in further detail at <u>www.franklincovey.com</u>. The information posted on our website is not incorporated into this report.

The accompanying unaudited condensed consolidated financial statements reflect, in the opinion of management, all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position and results of operations of the Company as of the dates and for the periods indicated. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. The information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

The results of operations for the quarter ended November 30, 2022 are not necessarily indicative of results expected for the entire fiscal year ending August 31, 2023, or for any future periods.

 **‎** 

------

**NOTE 2 – INVENTORIES**

Inventories are stated at the lower of cost or net realizable value, cost being determined using the first-in, first-out method, and were comprised of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | November 30, | August 31, |
|  | 2022 | 2022 |
| Finished goods | $3472 | $3519 |
| Raw materials | 5 | 8 |
|  | $3477 | $3527 |

---

**NOTE 3 – FAIR VALUE OF FINANCIAL INSTRUMENTS**

At November 30, 2022, the carrying value of our financial instruments approximated their fair values. The fair values of our contingent consideration liabilities from previous business acquisitions are considered "Level 3" measurements because we use various estimates in the valuation models to project the timing and amount of future contingent payments. The fair value of the contingent consideration liability from the acquisition of Jhana Education (Jhana) changed as follows during the quarter ended November 30, 2022 (in thousands):

---

| | |
|:---|:---|
| Balance at August 31, 2022 | $729  |
| Change in fair value | 7  |
| Payments | (429) |
| Balance at November 30, 2022 | $307  |

---

At each quarterly reporting date, we estimate the fair value of our contingent liability from the acquisition of Jhana through the use of a Monte Carlo simulation. Based on the timing of expected payments, all of the Jhana contingent consideration liability shown above was recorded in accrued liabilities at November 30, 2022. Adjustments to the fair value of our contingent consideration liabilities are included in selling, general, and administrative expense in the accompanying condensed consolidated income statements and statements of comprehensive income.

**NOTE 4 – REVENUE RECOGNITION**

**Contract Balances**

Our deferred revenue totaled $90.8 million at November 30, 2022 and $102.4 million at August 31, 2022, of which $2.5 million and $2.7 million were classified as components of other long-term liabilities at November 30, 2022, and August 31, 2022, respectively. The amount of deferred revenue that was generated from subscription offerings totaled $76.7 million at November 30, 2022 and $88.1 million at August 31, 2022. During the quarter ended November 30, 2022, we recognized $33.0 million of previously deferred subscription revenue.

Deferred subscription revenue primarily consists of billings or payments received in advance of revenue being recognized from subscription services. Deferred revenue is recognized in sales as the applicable revenue recognition criteria are met. We generally invoice customers in annual installments upon execution of a contract. With the *Leader in Me* offering, the contract includes both a subscription membership and onsite consulting which can be invoiced to the client in one lump sum. In this circumstance, the entire lump sum is included in deferred subscription revenue. The deferred subscription revenue related to the *Leader in Me* membership is recognized as revenue over the life of the contract whereas the consulting is recognized when the consulting takes place.

**Remaining Performance Obligations**

Whenever possible, we enter into multi-year non-cancellable contracts which are invoiced either upon execution of the contract or at the beginning of each annual contract period. Remaining transaction price represents contracted revenue that has not yet been recognized, including unearned revenue and unbilled amounts that will be recognized as revenue in future periods. Transaction price is influenced by factors such as inflation, the average length of the contract term, and the ability of the Company to continue to enter into multi-year non-cancellable contracts. At November 30, 2022, we had

------

$151.6 million of remaining performance obligations, including our deferred subscription revenue. The remaining performance obligation does not include other deferred revenue, as amounts included in other deferred revenue contain items such as deposits that are generally refundable at the client's request prior to the satisfaction of the obligation.

**Disaggregated Revenue Information**

Refer to Note 7, *Segment Information*, to these condensed consolidated financial statements for our disaggregated revenue information.

**NOTE 5 – STOCK-BASED COMPENSATION**

Our stock-based compensation was comprised of the following for the periods presented (in thousands):

---

| | | |
|:---|:---|:---|
|  | Quarter Ended | Quarter Ended |
|  | November 30, | November 30, |
|  | 2022 | 2021 |
| Long-term incentive awards | $2339  | $1123  |
| Strive acquisition compensation | 166  | 279  |
| Unvested stock awards | 165  | 175  |
| Employee stock purchase plan | 65  | 57  |
| Fully-vested share awards | - | 15  |
|  | $2735  | $1649  |

---

During the quarter ended November 30, 2022, we issued 56,045 shares of our common stock under various stock-based compensation arrangements, including our employee stock purchase plan (ESPP). Our stock-based compensation plans allow shares to be withheld to cover statutory income taxes if so elected by the award recipient. During the quarter ended November 30, 2022, we withheld 17,639 shares of our common stock for taxes on stock-based compensation arrangements, which had a total fair value of $0.8 million.

**Fiscal 2023 Long-Term Incentive Plan Award**

On October 14, 2022, the Compensation Committee granted a new LTIP award to our executive officers and members of senior management. The fiscal 2023 LTIP award has two tranches, one with a time-based vesting condition and one with a performance-based vesting condition as described below:

**Time-Based Award Shares** – Twenty-five percent of the 2023 LTIP award shares vest to participants on August 31, 2025. The number of shares that may be earned by participants at the end of the service period totals approximately 23,000 shares. The number of shares awarded in this tranche does not fluctuate based on the achievement of financial measures.

**Performance-Based Award Shares** – The remaining shares of the fiscal 2023 LTIP award are earned based on the highest rolling four-quarter level of qualified adjusted earnings before interest, income taxes, depreciation, amortization, and certain other charges (Adjusted EBITDA) achieved in the three-year period ending August 31, 2025. The number of shares that will vest to participants for this tranche is variable and may be 50 percent of the award (minimum award threshold) or up to 200 percent of the participant's award (maximum threshold) depending on the level of qualified Adjusted EBITDA achieved. The number of shares that may be earned for achieving 100 percent of the performance-based objective totals approximately 70,000 shares. The maximum number of shares that may be awarded in connection with the performance-based tranche of the 2022 LTIP totals approximately 140,000 shares.

**New Long-Term Incentive Plan**

During the quarter ended November 30, 2022, we introduced a new long-term equity incentive plan for client partners, managing directors, and certain other associates that we believe are critical to our long-term success. These awards are generally based on the achievement of specified sales goals and are expected to be granted annually. One-third of the award shares will vest to participants on each August 31 following the award grant. For performance in fiscal 2022, we

------

granted a total of approximately 34,000 unvested share units to the participants in this long-term incentive plan. The compensation cost of these awards is included in the long-term incentive awards category in the preceding table.

**Employee Stock Purchase Plan**

We have an employee stock purchase plan that offers qualified employees the opportunity to purchase shares of our common stock at a price equal to 85 percent of the average fair market value of our common stock on the last trading day of each fiscal quarter. During the quarter ended November 30, 2022, we issued 9,093 shares of our common stock to participants in the ESPP.

**NOTE 6 – NET INCOME PER SHARE**

The following schedule shows the calculation of net income per share for the periods presented (in thousands, except per-share amounts).

---

| | | |
|:---|:---|:---|
|  | Quarter Ended | Quarter Ended |
|  | November 30, | November 30, |
|  | 2022 | 2021 |
| **Numerator for basic and** |  |  |
| &nbsp;&nbsp;**diluted loss per share:** |  |  |
| Net income | $4667 | $3812  |
| **Denominator for basic and** |  |  |
| &nbsp;&nbsp;**diluted loss per share:** |  |  |
| Basic weighted average shares |  |  |
| &nbsp;&nbsp;outstanding | 13877 | 14246  |
| Effect of dilutive securities: |  |  |
| &nbsp;&nbsp;Other stock-based awards | 630 | 66  |
| Diluted weighted average |  |  |
| &nbsp;&nbsp;shares outstanding | 14507 | 14312  |
| **EPS Calculations:** |  |  |
| Net income per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.34 | $0.27  |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 0.32 | 0.27  |

---

**NOTE 7 – SEGMENT INFORMATION**

**Segment Information**

Our sales are primarily comprised of training and consulting services and our internal reporting and operating structure is currently organized around two divisions. The Enterprise Division, which consists of our Direct Office and International Licensee segments and the Education Division, which is comprised of our Education practice. Based on the applicable guidance, our operations are comprised of three reportable segments and one corporate services group. The following is a brief description of our reportable segments:

***Direct Offices –*** Our Direct Office segment has a depth of expertise in helping organizations solve problems that require changes in human behavior, including leadership, productivity, execution, trust, and sales performance. We have a variety of principle-based offerings that help build winning and profitable cultures. This segment includes our sales personnel that serve the United States and Canada; our international sales offices located in Japan, China, the United Kingdom, Australia, Germany, Switzerland, and Austria; our government services sales channel; and our book and audio sales.

***International Licensees –*** Our independently owned international licensees provide our offerings and services in countries where we do not have a directly-owned office. These licensee partners allow us to expand the reach of

------

our services to large multinational organizations as well as smaller organizations in their countries. This segment's results are primarily comprised of royalty revenues received from these licensees.

***Education Practice –*** Centered around the principles found in *The Leader in Me*, the Education practice is dedicated to helping educational institutions build a culture that will produce great results. We believe these results are manifested by increases in student performance, improved school culture, decreased disciplinary issues, and increased teacher engagement and parental involvement. This segment includes our domestic and international Education practice operations, which are focused on sales to educational institutions such as elementary schools, high schools, and colleges and universities.

***Corporate and Other –*** Our corporate and other information includes leasing operations, shipping and handling revenues, royalty revenues from Franklin Planner Corp., and the cost of certain corporate administrative functions.

We have determined that the Company's chief operating decision maker is the Chief Executive Officer, and the primary measurement tool used in business unit performance analysis is Adjusted EBITDA, which may not be calculated as similarly titled amounts disclosed by other companies. Adjusted EBITDA is a non-GAAP financial measure. For reporting purposes, our consolidated Adjusted EBITDA may be calculated as net income excluding interest, income taxes, depreciation expense, intangible asset amortization expense, stock-based compensation, and certain other charges such as adjustments for changes in the fair value of contingent liabilities arising from business acquisitions. We reference this non-GAAP financial measure in our decision making because it provides supplemental information that facilitates consistent internal comparisons to the historical operating performance of prior periods and we believe it provides investors with greater transparency to evaluate operational activities and financial results.

We account for the following segment information on the same basis as the accompanying condensed consolidated financial statements (in thousands).

---

| | | | |
|:---|:---|:---|:---|
|  | Sales to |  |  |
| ***Quarter Ended*** | External |  | Adjusted |
| ***November 30, 2022*** | Customers | Gross Profit | EBITDA |
| Enterprise Division: |  |  |  |
| &nbsp;&nbsp;Direct offices | $50167  | $39921  | $11250  |
| &nbsp;&nbsp;International licensees | 3278  | 2977  | 1831  |
|  | 53445  | 42898  | 13081  |
| Education practice | 14350  | 9175  | 281  |
| Corporate and eliminations | 1574  | 669  | (1890) |
| &nbsp;&nbsp;Consolidated | $69369  | $52742  | $11472  |
| ***Quarter Ended*** |  |  |  |
| ***November 30, 2021*** |  |  |  |
| Enterprise Division: |  |  |  |
| &nbsp;&nbsp;Direct offices | $45119  | $36202  | $9954  |
| &nbsp;&nbsp;International licensees | 2997  | 2701  | 1671  |
|  | 48116  | 38903  | 11625  |
| Education practice | 11697  | 7860  | 235  |
| Corporate and eliminations | 1446  | 835  | (1928) |
| &nbsp;&nbsp;Consolidated | $61259  | $47598  | $9932  |

---

‎

------

A reconciliation of our consolidated Adjusted EBITDA to consolidated net income is provided below (in thousands).

---

| | | |
|:---|:---|:---|
|  | Quarter Ended | Quarter Ended |
|  | November 30, | November 30, |
|  | 2022 | 2021 |
| Segment Adjusted EBITDA | $13362  | $11860  |
| Corporate expenses | (1890) | (1928) |
| Consolidated Adjusted EBITDA | 11472  | 9932  |
| Stock-based compensation | (2735) | (1649) |
| Increase in the fair value of |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;contingent consideration liabilities | (7) | (28) |
| Depreciation | (1246) | (1279) |
| Amortization | (1092) | (1431) |
| &nbsp;&nbsp;Income from operations | 6392  | 5545  |
| Interest income | 81  | 15  |
| Interest expense | (410) | (446) |
| &nbsp;&nbsp;Income before income taxes | 6063  | 5114  |
| Income tax provision | (1396) | (1302) |
| &nbsp;&nbsp;Net income | $4667 | $3812  |

---

**Revenue by Category**

The following table presents our revenue disaggregated by geographic region (in thousands).

---

| | | |
|:---|:---|:---|
|  | Quarter Ended | Quarter Ended |
|  | November 30, | November 30, |
|  | 2022 | 2021 |
| Americas | $56743 | $48755  |
| Asia Pacific | 7458 | 7797  |
| Europe/Middle East/Africa | 5168 | 4707  |
|  | $69369 | $61259  |

---

The following table presents our revenue disaggregated by type of service (in thousands).

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| ***Quarter Ended*** | Services and |  |  | Leases and |  |
| ***November 30, 2022*** | Products | Subscriptions | Royalties | Other | Consolidated |
| Enterprise Division: |  |  |  |  |  |
| &nbsp;&nbsp;Direct offices | $26217 | $23490 | $460 | $- | $50167 |
| &nbsp;&nbsp;International licensees | 143 | 352 | 2783 | - | 3278 |
|  | 26360 | 23842 | 3243 | - | 53445 |
| Education practice | 4500 | 9183 | 667 | - | 14350 |
| Corporate and eliminations | - | - | 315 | 1259 | 1574 |
| &nbsp;&nbsp;Consolidated | $30860 | $33025 | $4225 | $1259 | $69369 |
| ***Quarter Ended*** |  |  |  |  |  |
| ***November 30, 2021*** |  |  |  |  |  |
| Enterprise Division: |  |  |  |  |  |
| &nbsp;&nbsp;Direct offices | $23851  | $20512  | $756  | $- | $45119  |
| &nbsp;&nbsp;International licensees | 404  | - | 2593  | - | 2997  |
|  | 24255  | 20512  | 3349  | - | 48116  |
| Education practice | 3226  | 7844  | 627  | - | 11697  |
| Corporate and eliminations | - | - | 344  | 1102  | 1446  |
| &nbsp;&nbsp;Consolidated | $27481  | $28356  | $4320  | $1102  | $61259  |

---

------

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management's discussion and analysis contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon management's current expectations and are subject to various uncertainties and changes in circumstances. Important factors that could cause actual results to differ materially from those described in forward-looking statements are set forth below under the heading "Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995."

We suggest that the following discussion and analysis be read in conjunction with the Consolidated Financial Statements and Management's Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022 as filed with the SEC on November 14, 2022.

**Non-GAAP Measures**

This Management's Discussion and Analysis includes the concepts of adjusted earnings before interest, income taxes, depreciation, and amortization (Adjusted EBITDA) and "constant currency," which are non-GAAP measures. We define Adjusted EBITDA as net income excluding the impact of interest, income taxes, intangible asset amortization, depreciation, stock-based compensation expense, and certain other items such as adjustments to the fair value of expected contingent consideration liabilities arising from business acquisitions. Constant currency is a non-GAAP financial measure that removes the impact of fluctuations in foreign currency exchange rates and is calculated by translating the current period's financial results at the same average exchange rates in effect during the prior year and then comparing this amount to the prior year.

We reference these non-GAAP financial measures in our decision making because they provide supplemental information that facilitates consistent internal comparisons to the historical operating performance of prior periods and we believe it provides investors with greater transparency to evaluate operational activities and financial results. For a reconciliation of our segment Adjusted EBITDA to net income, a related GAAP measure, please refer to Note 7, *Segment Information,* to our financial statements.

**RESULTS OF OPERATIONS**

**Overview**

Franklin Covey Co. is a global company focused on individual and organizational performance improvement. Our mission is to "enable greatness in people and organizations everywhere," and our worldwide resources are organized to help individuals and organizations achieve sustained superior performance at scale through changes in human behavior. We believe that our content and services create the connection between capabilities and results. Our business is currently structured around two divisions, the Enterprise Division and the Education Division. The Enterprise Division consists of our Direct Office and International Licensee segments and is focused on selling our offerings to corporations, governments, not-for-profits, and other related organizations. Our offerings delivered through the Enterprise Division are designed to help organizations and individuals achieve their own great results. Our Education Division is centered around the principles found in *The Leader in Me* and is dedicated to helping educational institutions build cultures that will produce great results, including increased student performance, improved school culture, and increased parental and teacher involvement.

Our financial results for the quarter ended November 30, 2022 maintained the strong momentum that was generated in fiscal 2022 and included increased sales, increased gross profit, increased operating and net income, and higher Adjusted EBITDA. Our consolidated sales for the first quarter of fiscal 2023 increased 13 percent, or $8.1 million, to $69.4 million compared with $61.3 million in fiscal 2022. On a constant currency basis, our consolidated sales for the first quarter increased 17 percent to $71.4 million. Rolling four-quarter consolidated sales increased 14 percent to $271.0 million compared with the four-quarters ended November 30, 2021. Our strong start to fiscal 2023 reflects the continuation of three key trends that have been evident throughout the preceding fiscal year and that have significantly contributed to our financial results. These trends include:

‎

------

*Strong growth of All Access Pass and Related Services*. All Access Pass (AAP) subscription and subscription services sales increased 20 percent in the first quarter of fiscal 2023 to $39.6 million. Rolling four-quarter AAP subscription and subscription services sales increased 26 percent to $151.0 million.

*Education Division performance improvement*. Education Division revenues grew 23 percent on the strength of increased consulting, coaching, and training days delivered during the quarter, increased *Leader in Me* subscription revenues, and increased material sales.

*International sales improvement*. Three of our five international direct offices reported improved sales compared with the first quarter of fiscal 2022 and international licensee revenues increased nine percent over the prior year, reflecting increased sales and improving economic conditions in many of the countries in which we and our licensees operate. We expect sales activity in Asia to improve in future periods as pandemic-related measures are relieved and economies recover.

We were pleased with our overall sales growth during the quarter despite some continuing international headwinds, including unfavorable foreign exchange rates, a 10 percent decrease in China office sales, and a six percent decrease in Japan office sales primarily due to pandemic mitigation measures and economic conditions in those countries. Foreign exchange rates had a $2.0 million adverse impact on the Company's sales during the first quarter of fiscal 2023.

The following is a summary of financial highlights for the first quarter of fiscal 2023:

***Sales* –** Our consolidated sales for the quarter ended November 30, 2022 increased 13 percent, or $8.1 million, to $69.4 million compared with $61.3 million in the prior year. We continue to be pleased with the strength of our All Access Pass and *Leader in Me* subscription-based services and believe these services will drive consistent sales growth in fiscal 2023 and in future periods. For the first quarter, Enterprise Division sales increased 11 percent, or $5.3 million, to $53.4 million compared with $48.1 million in fiscal 2022, despite $2.0 million of unfavorable foreign exchange and decreased sales in China and Japan during the quarter as previously described. During the first quarter of fiscal 2023, AAP and related sales increased 20 percent compared with the prior year and annual revenue retention remained strong at well above 90 percent. Education Division sales grew 23 percent compared with the prior year on the strength of increased consulting, coaching, and training days delivered during the quarter, increased *Leader in Me* subscription revenue, and increased material sales. During the first quarter of fiscal 2023, sales improved in each of our Direct Office, International Licensee, and Education Division segments compared with the first quarter of fiscal 2022.

At November 30, 2022, we had $76.7 million of deferred subscription revenue on our balance sheet, a 13 percent, or $8.9 million, increase compared with deferred subscription revenue at November 30, 2021. At November 30, 2022, we had $74.9 million of unbilled deferred revenue compared with $53.4 million of unbilled deferred revenue at November 30, 2021. Unbilled deferred revenue represents business that is contracted but unbilled (primarily from multiyear subscription contracts), and excluded from our balance sheet. As of November 30, 2022 approximately 48 percent of our AAP contracts are multi-year arrangements.

***Cost of Sales/Gross Profit*** – Our cost of sales totaled $16.6 million for the quarter ended November 30, 2022, compared with $13.7 million in the first quarter of the prior year. Gross profit for the first quarter of fiscal 2023 increased 11 percent to $52.7 million compared with $47.6 million in fiscal 2022. Our gross margin in the first quarter of fiscal 2023 remained strong at 76.0 percent of sales compared with 77.7 percent in the prior year, reflecting changes in the mix of services and products in sold. Cost of goods sold and gross profit each increased primarily due to higher sales as described above.

------

***Operating Expenses*** – Our operating expenses for the quarter ended November 30, 2022 increased $4.3 million compared with the same quarter of the prior year, which was primarily due to a $4.7 million increase in selling, general, and administrative (SG&A) expenses. Despite the increase in SG&A expenses, as a percent of sales, our SG&A expenses in the first quarter of fiscal 2023 decreased to 63.4 percent compared with 64.2 percent in the prior year. Our SG&A expenses increased primarily due to increased associate costs resulting from new personnel and increased salaries; increased commissions on higher sales; and increased travel expense. At November 30, 2022, we had 292 client partners compared with 271 client partners at November 30, 2021.

***Operating Income, Net Income, and Adjusted EBITDA*** – As a result of increased sales and a strong gross margin, our income from operations for the quarter ended November 30, 2022 improved 15 percent to $6.4 million, compared with $5.5 million in the first quarter of fiscal 2022. Comparative first quarter fiscal 2023 net income was $4.7 million, or $0.32 per diluted share, compared with $3.8 million, or $0.27 per diluted share, in fiscal 2022. Our Adjusted EBITDA for the quarter ended November 30, 2022 improved 16 percent to $11.5 million, compared with $9.9 million in the first quarter of the prior year.

***Liquidity and Financial Position –*** Our liquidity and financial position remained strong during the first quarter of fiscal 2023. At November 30, 2022, we had $58.2 million of cash with no borrowings on our $15.0 million secured line of credit facility, compared with $60.5 million, and no borrowings on our credit facility, at August 31, 2022.

Further details regarding our results for the quarter ended November 30, 2022 are provided throughout the following management's discussion and analysis.

**<u>Quarter Ended November 30, 2022 Compared with the Quarter Ended November 30, 2021</u>**

**Enterprise Division**

*<u>Direct Offices Segment</u>*

The Direct Office segment includes our sales personnel that serve clients in the United States and Canada; our directly owned international offices in Japan, China, the United Kingdom, Australia, Germany, Switzerland, and Austria; and other groups such as our government services office and books and audio sales. The following comparative information is for our Direct Offices segment for the periods indicated (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Quarter Ended |  | Quarter Ended |  |  |
|  | November 30, | % of | November 30, | % of |  |
|  | 2022 | Sales | 2021 | Sales | Change |
| Sales | $50167 | 100.0 | $45119 | 100.0  | $5048 |
| Cost of sales | 10246 | 20.4 | 8917 | 19.8 | 1329 |
| Gross profit | 39921 | 79.6 | 36202 | 80.2 | 3719 |
| SG&A expenses | 28671 | 57.2 | 26248 | 58.2 | 2423 |
| Adjusted EBITDA | $11250 | 22.4 | $9954 | 22.1 | $1296 |

---

During the first quarter of fiscal 2023, Direct Office segment revenue increased 11 percent to $50.2 million compared with $45.1 million in fiscal 2022. The increase was primarily the result of strong performance in our offices in the United States and Canada where revenue increased 16 percent in the quarter, but was partially offset by $1.6 million of unfavorable foreign currency exchange and decreased sales from our China and Japan offices. During the first quarter of fiscal 2022 our AAP subscription and subscription related revenues remained strong and increased 20 percent over the first quarter of fiscal 2022, while annual AAP revenue retention remained well above 90 percent. The sum of deferred subscription revenue on our balance sheet combined with unbilled multi-year contracts entered into, increased 25 percent to $151.6 million, compared with November 30, 2021. We believe the continued increase in invoiced AAP and other subscription sales, which are initially recognized on the balance sheet, provide a solid base for continued revenue growth in future periods.

Consistent with the previous several quarters, the performance of our international direct offices was directly related to the level of recovery from the pandemic and corresponding business and social activity in each country. Increased sales in

------

the United Kingdom, Australia, and Germany/Switzerland/Austria offices were offset by decreased sales in China and Japan. During fiscal 2022, China had a resurgence of COVID cases and enacted strict lockdown measures in response to the rise in cases. These continuing lockdown measures and related social unrest adversely impacted our China office during first quarter of fiscal 2023 and led to a 10 percent reduction in quarter-over-quarter sales. Sales in our Japan office decreased by six percent compared to the prior year and were hampered by economic activity and the fear of resurging COVID cases. While we remain confident in our international direct offices' ability to grow in future periods, growth in our China and Japan offices may continue to be negatively impacted by significant ongoing governmental pandemic-related mandates, unfavorable economic conditions, and social unrest in fiscal 2023 and future periods. Foreign exchange rates had a $1.6 million unfavorable impact on our Direct Office sales and a $0.4 million unfavorable effect on operating income during the opening quarter of fiscal 2023.

*Gross Profit.* Gross profit increased primarily due to increased sales as previously described. Direct Office gross margin remained strong, and was 79.6 percent compared with 80.2 percent in the prior year.

*SG&A Expense.* Direct Office SG&A expense increased primarily due to increased associate costs resulting from new personnel, increased salaries, and increased commissions on higher sales, and increased travel expenses.

*<u>International Licensees Segment</u>*

In foreign locations where we do not have a directly owned office, our training and consulting services are delivered through independent licensees. The following comparative information is for our international licensee operations in the periods indicated (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Quarter Ended |  | Quarter Ended |  |  |
|  | November 30, | % of | November 30, | % of |  |
|  | 2022 | Sales | 2021 | Sales | Change |
| Sales | $3278 | 100.0 | $2997 | 100.0  | $281 |
| Cost of sales | 301 | 9.2 | 296 | 9.9 | 5 |
| Gross profit | 2977 | 90.8 | 2701 | 90.1 | 276 |
| SG&A expenses | 1146 | 35.0 | 1030 | 34.4 | 116 |
| Adjusted EBITDA | $1831 | 55.9 | $1671 | 55.8 | $160 |

---

*Sales.* International licensee revenues are primarily comprised of royalty revenues. During the first quarter of fiscal 2023 our licensee revenues increased primarily due to increased royalty revenues from certain licensees as economies in many of the countries where our licensees operate continue to recover from the pandemic. The ongoing recovery led to improved licensee royalty revenues and continued increases in our share of AAP sales. Compared with the first quarter of fiscal 2022, our royalty revenues increased seven percent and our share of AAP revenues increased by 32 percent to $0.4 million. We receive additional revenue from the international licensees for AAP sales to cover a portion of the costs of operating the AAP portal. We remain optimistic that the recovery of international economies in future periods will benefit our licensees' sales and our corresponding royalty revenues. However, macroeconomic conditions, such as foreign exchange rates and inflation, are not within our control and may negatively impact our licensees' operations and our royalty revenues in future periods. Foreign exchange rates had a $0.3 million adverse impact on international licensee sales and operating results during the quarter ended November 30, 2022.

*Gross Profit*. Gross profit increased primarily due to increased royalty revenues and AAP revenues as previously described. Gross margin remained strong at 90.8 percent compared with 90.1 percent in the prior year, and improved slightly due to the mix of revenue recognized during the first quarter of fiscal 2023.

*SG&A Expense.* International licensee SG&A expenses increased primarily due to additional spending on technology, development, and various other shared service costs.

**Education Division**

Our Education Division is comprised of our domestic and international Education practice operations (focused on sales to educational institutions) and includes our widely acclaimed *Leader in Me* program. The following comparative information is for our Education Division for the periods indicated (in thousands):

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Quarter Ended |  | Quarter Ended |  |  |
|  | November 30, | % of | November 30, | % of |  |
|  | 2022 | Sales | 2021 | Sales | Change |
| Sales | $14350 | 100.0 | $11697 | 100.0  | $2653 |
| Cost of sales | 5175 | 36.1 | 3837 | 32.8 | 1338 |
| Gross profit | 9175 | 63.9 | 7860 | 67.2 | 1315 |
| SG&A expenses | 8894 | 62.0 | 7625 | 65.2 | 1269 |
| Adjusted EBITDA | $281 | 2.0 | $235 | 2.0 | $46 |

---

*Sales.* Education Division sales for the quarter ended November 30, 2022 grew 23 percent, or $2.7 million, primarily due to increased consulting, coaching, and training days delivered during the quarter, increased *Leader in Me* subscription revenue, and increased training material sales compared with the prior year. Education subscription and subscription service sales increased 17 percent over the first quarter of fiscal 2022. We are pleased with the continued strength and momentum of our Education Division, which added a record 739 new *Leader in Me* schools during fiscal 2022. We believe this positive momentum generated in fiscal 2022 and the first quarter of fiscal 2023 will continue through the remainder of fiscal 2023. As of November 30, 2022, the *Leader in Me* program is used in over 3,400 schools in the United States and Canada.

*Gross Profit.* Education Division gross profit increased primarily due to sales growth as previously described. Education segment gross margin decreased compared with the prior year primarily due to increased costs related to the delivery of coaching and consulting services and related training materials. Education division gross margin was also adversely impacted by a change in the mix of services and products sold to customers compared with the prior year.

*SG&A Expenses.* Education SG&A expenses increased primarily due to increased associate expenses from new personnel and changes to compensation plans, and increased travel costs compared with the prior year.

**Other Operating Expense Items**

***Depreciation –*** Depreciation expense for the first quarter was $1.2 million compared with $1.3 million in the same quarter of fiscal 2022, and decreased primarily due to the full depreciation of certain assets. We currently expect depreciation expense will total approximately $5.7 million in fiscal 2023.

***Amortization* –** Amortization expense decreased $0.3 million compared with the prior year due full amortization of certain intangible assets from previous business acquisitions. We currently expect definite-lived intangible asset amortization expense will total $4.3 million during fiscal 2023.

**Income Taxes**

Our income tax provision for the quarter ended November 30, 2022 was $1.4 million compared with an income tax provision of $1.3 million in the same quarter of the prior year. Our effective tax rate for the first quarter was generally consistent with the prior year at 23.0 percent in fiscal 2023, compared with 25.5 percent in fiscal 2022. We paid $0.8 million in cash for income taxes during the first quarter of fiscal 2023 and we anticipate that our total cash paid for income taxes over the coming three to five years will be less than our total income tax provision to the extent we are able to utilize net operating loss carryforwards, foreign tax credit carryforwards, and other deferred income tax assets.

**LIQUIDITY AND CAPITAL RESOURCES**

**Introduction**

Due to economic uncertainties generated by a variety of current geopolitical events, including macroeconomic factors, international conflicts, and the ongoing impacts from the COVID-19 pandemic, we have prioritized maintaining and preserving adequate liquidity during the past few years. We believe these efforts have been successful and have provided the ability to maintain operations, make strategic investments, and purchase shares of our common stock. At November 30, 2022, our cash and cash equivalents totaled $58.2 million, with no borrowings on our $15.0 million revolving credit facility. Of our $58.2 million of cash at November 30, 2022, $15.5 million was held at our foreign subsidiaries. We routinely repatriate cash from our foreign subsidiaries and consider cash generated from foreign activities a key component of our overall liquidity position. Our primary sources of liquidity are cash flows from the sale of services in

------

the normal course of business and available proceeds from our revolving line of credit facility. Our primary uses of liquidity include payments for operating activities, debt payments, business acquisitions, capital expenditures (including curriculum development), working capital expansion, and purchases of our common stock.

At November 30, 2022, our debt covenants consisted of the following: (i) a Funded Indebtedness to Adjusted EBITDAR Ratio of less than 3.00 to 1.00; (ii) a Fixed Charge Coverage ratio not less than 1.15 to 1.00; (iii) an annual limit on capital expenditures (excluding capitalized curriculum development costs) of $8.0 million; and (iv) consolidated accounts receivable of not less than 150 percent of the aggregate amount of the outstanding borrowings on the revolving line of credit, the undrawn amount of outstanding letters of credit, and the amount of unreimbursed letter of credit disbursements.

In the event of noncompliance with these financial covenants and other defined events of default, the lender is entitled to certain remedies, including acceleration of the repayment of any amounts outstanding on the credit agreement entered into on August 7, 2019 (the 2019 Credit Agreement). At November 30, 2022, we believe that we were in compliance with the terms and covenants applicable to the 2019 Credit Agreement and subsequent modifications.

In addition to our term-loan obligation and borrowings on our revolving line of credit, we have a long-term rental agreement on our corporate campus that is accounted for as a financing obligation.

The following discussion is a description of the primary factors affecting our cash flows and their effects upon our liquidity and capital resources during the quarter ended November 30, 2022.

**Cash Flows Provided By Operating Activities**

Our primary source of cash from operating activities was the sale of services to our customers in the normal course of business. Our primary uses of cash for operating activities were payments for SG&A expenses, to fund changes in working capital, payments for direct costs necessary to conduct training programs, and payments to suppliers for materials used in training manuals sold. Our cash provided by operating activities during the first quarter of fiscal 2023 was $3.0 million compared with $10.2 million in the first quarter of fiscal 2022. The difference was primarily attributable to changes in working capital during the quarter. During the first quarter of fiscal 2023 our collection of accounts receivable remained strong and provided the necessary cash to support our operations, pay our obligations, and make critical investments.

**Cash Flows Used For Investing Activities and Capital Expenditures**

During the quarter ended November 30, 2022, our cash used for investing activities totaled $2.2 million. Our primary uses of cash for investing activities were purchases of property and equipment in the normal course of business and additional investments in the development of our offerings.

Our purchases of property and equipment during the first quarter of fiscal 2023 consisted primarily of computer hardware, software, and leasehold improvements on our corporate campus. We expect to continue investing in our content and delivery modalities, including the AAP and *Leader in Me* subscription services and expect to make required leasehold improvements on our corporate campus in fiscal 2023 and in future periods. We currently anticipate that our purchases of property and equipment will total $7.6 million in fiscal 2023.

We spent $1.0 million during the first quarter of fiscal 2023 on the development of various content and offerings. We believe continued investment in our content and offerings is key to future growth and the development of our subscription offerings. We currently expect that our capital spending for curriculum development will increase during the remainder of fiscal 2023 and will total $9.5 million for the fiscal year.

**Cash Flows Used For Financing Activities**

For the quarter ended November 30, 2022, our net cash used for financing activities totaled $2.9 million. Our primary uses of financing cash included $2.0 million used for principal payments on our term loan and financing obligations, $0.8 million used to purchase shares of our common stock, and $0.4 million used to pay contingent consideration liabilities from previous business acquisitions. Our purchases of common stock during the first quarter of fiscal 2023 were comprised entirely of shares withheld from participants to pay statutory income taxes on stock-based compensation

------

awards. Partially offsetting these uses of cash were $0.4 million of proceeds from Employee Stock Purchase Plan participants to purchase shares of stock during the first quarter of fiscal 2023.

On November 15, 2019, our Board of Directors approved a new plan to repurchase up to $40.0 million of the Company's outstanding common stock. The previously existing common stock repurchase plan was canceled and the new common share repurchase plan does not have an expiration date. At November 30, 2022, we have $19.5 million remaining in the current purchase authorization. Our uses of financing cash during the remainder of fiscal 2023 are expected to include required payments on our term loans and financing obligation, contingent consideration payments from previous business acquisitions, and may include purchases of our common stock. However, the timing and amount of common stock purchases is dependent on a number of factors, including available resources, and we are not obligated to make purchases of our common stock during any future period.

**Sources of Liquidity**

We expect to meet our obligations on the 2019 Credit Agreement, service our existing financing obligation, pay for projected capital expenditures, and meet other obligations during fiscal 2023 from current cash balances and future cash flows from operating activities. Going forward, we will continue to incur costs necessary for the day-to-day operation of the business and may use additional credit and other financing alternatives, if necessary, for these expenditures. Our 2019 Credit Agreement expires in August 2024 and we expect to renew and amend the 2019 Credit Agreement on a regular basis to maintain the long-term borrowing capacity of this credit facility. Additional potential sources of liquidity available to us include factoring receivables, issuance of additional equity, or issuance of debt to public or private sources. If necessary, we will evaluate all of these options and select one or more of them depending on overall capital needs and the associated cost of capital.

We believe that our existing cash and cash equivalents, cash generated by operating activities, and the availability of external funds as described above, will be sufficient for us to maintain our operations for at least the upcoming 12 months. However, our ability to maintain adequate capital for our operations in the future is dependent upon a number of factors, including sales trends, macroeconomic activity, the length and severity of business disruptions associated with the COVID-19 pandemic (and new variants), our ability to contain costs, levels of capital expenditures, collection of accounts receivable, and other factors. Some of the factors that influence our operations are not within our control, such as general economic conditions and the introduction of new offerings or technology by our competitors. We will continue to monitor our liquidity position and may pursue additional financing alternatives, as described above, to maintain sufficient resources for future growth and capital requirements. However, there can be no assurance such financing alternatives will be available to us on acceptable terms, or at all.

**Material Uses of Cash and Contractual Obligations**

We do not operate any manufacturing, mining, or other capital-intensive facilities, and we have not structured any special purpose entities, or participated in any commodity trading activities, which would expose us to potential undisclosed liabilities or create adverse consequences to our liquidity. However, we have normal ongoing cash expenditures and are subject to various contractual obligations that are required to run our business. Our material cash requirements include the following:

Associate and Consultant Compensation

Information Technology Expenditures

Content Development Costs

Income Taxes

Contractual Obligations

These material cash requirements are discussed in more detail in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022. During the first quarter of fiscal 2023, there have been no material changes to our expected uses of cash and contractual obligations from those discussed in our Annual Report for the fiscal year ended August 31, 2022. However, current economic conditions and forecasts indicate that our material uses of cash may increase due to inflationary pressures in the upcoming months. For further information on our material uses of cash and contractual obligations, refer

------

to the information included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022, which was filed with the Securities and Exchange Commission on November 14, 2022.

**CRITICAL ACCOUNTING ESTIMATES**

Our consolidated financial statements were prepared in accordance with GAAP. The significant accounting policies used to prepare our consolidated financial statements are outlined primarily in Note 1 to the consolidated financial statements presented in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended August 31, 2022. Please refer to these disclosures for further information regarding our uses of estimates and critical accounting policies. There have been no significant changes to our previously disclosed estimates or critical accounting policies.

**Estimates**

Some of the accounting guidance we use requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements. We regularly evaluate our estimates and assumptions and base those estimates and assumptions on historical experience, factors that are believed to be reasonable under the circumstances, and requirements under GAAP. Actual results may differ from these estimates under different assumptions or conditions, including changes in economic conditions and other circumstances that are not within our control, but which may have an impact on these estimates and our actual financial results.

**SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995**

Certain statements made by the Company in this report are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act). Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements, and may contain words such as "believe," "anticipate," "expect," "estimate," "project," or words or phrases of similar meaning. In our reports and filings we may make forward-looking statements regarding, among other things, our expectations about future sales levels and financial results, our financial performance during fiscal 2023, expected and lingering effects from the COVID-19 pandemic, including effects on how we conduct our business and our results of operations, the timing and duration of the recovery from the COVID-19 pandemic, future training and consulting sales activity, expected benefits from the AAP and the electronic delivery of our content, anticipated renewals of subscription offerings, our ability to hire sales professionals, the amount and timing of capital expenditures, anticipated expenses, including SG&A expenses, depreciation, and amortization, future gross margins, the release of new services or products, the adequacy of existing capital resources, our ability to renew or extend our line of credit facility, the amount of cash expected to be paid for income taxes, our ability to maintain adequate capital for our operations for at least the upcoming 12 months, the seasonality of future sales, future compliance with the terms and conditions of our line of credit, the ability to borrow on our line of credit, expected collection of accounts receivable, estimated capital expenditures, and cash flow estimates used to determine the fair value of long-lived assets. These, and other forward-looking statements, are subject to certain risks and uncertainties that may cause actual results to differ materially from the forward-looking statements. These risks and uncertainties are disclosed from time to time in reports filed by us with the SEC, including reports on Forms 8-K, 10-Q, and 10-K. Such risks and uncertainties include, but are not limited to, the matters discussed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended August 31, 2022, entitled "Risk Factors." In addition, such risks and uncertainties may include unanticipated developments in any one or more of the following areas: cybersecurity risks; inflation and other macroeconomic risks; unanticipated costs or capital expenditures; delays or unanticipated outcomes relating to our strategic plans; dependence on existing products or services; the rate and consumer acceptance of new product introductions, including the All Access Pass; competition; the impact of foreign exchange rates; the number and nature of customers and their product orders, including changes in the timing or mix of product or training orders; pricing of our products and services and those of competitors; adverse publicity; and other factors which may adversely affect our business.

The risks included here are not exhaustive. Other sections of this report may include additional factors that could adversely affect our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors may emerge and it is not possible for our management to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any single factor, or combination of factors, may cause actual results to differ materially from those contained in forward-looking statements.

------

Given these risks and uncertainties, investors should not rely on forward-looking statements as a prediction of actual results.

The market price of our common stock has been and may remain volatile. In addition, the stock markets in general have experienced increased volatility. Factors such as quarter-to-quarter variations in revenues and earnings or losses and our failure to meet expectations could have a significant impact on the market price of our common stock. In addition, the price of our common stock can change for reasons unrelated to our performance. Due to our low market capitalization, the price of our common stock may also be affected by conditions such as a lack of analyst coverage and fewer potential investors.

Forward-looking statements are based on management's expectations as of the date made, and we do not undertake any responsibility to update any of these statements in the future except as required by law. Actual future performance and results will differ and may differ materially from that contained in or suggested by forward-looking statements as a result of the factors set forth in this Management's Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in our filings with the SEC.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

**Interest Rate Sensitivity**

At November 30, 2022, our long-term obligations primarily consisted of term loans payable, a long-term lease agreement (financing obligation) on our corporate headquarters facility, fixed-rate notes payable from the purchase of Strive Talent, Inc., and deferred payments and potential contingent consideration resulting from previous business acquisitions. Since most of our long-term obligations have a fixed interest rate, our overall interest rate sensitivity is primarily influenced by any amounts borrowed on term loans and our revolving line of credit facility, and the prevailing interest rates on these instruments. The effective interest rate on our term loans payable and line of credit facility is variable and was 5.7 percent at November 30, 2022. Based on expected increases in interest rates over the remainder of fiscal 2023 and into fiscal 2024, we will incur additional expense on our variable-rate loans in future periods. For example, a one percent increase in the effective interest rate on our unpaid term loans at November 30, 2022 would result in $0.1 million of additional interest expense over the next 12 months. Our financing obligation has a payment structure equivalent to a long-term leasing arrangement with a fixed interest rate of 7.7 percent, and our contingent consideration liabilities are not subject to interest rate fluctuations.

The interest rate on our 2019 Credit Agreement is currently based upon published LIBOR rates, which are expected to be discontinued in the future. The provisions of the 2019 Credit Agreement address the eventual transition away from LIBOR pricing and provide alternative interest rate pricing. We do not have any other material contracts which are dependent upon LIBOR pricing and we believe that we are prepared for the discontinuation of LIBOR rate pricing.

There have been no other material changes from the information previously reported under Item 7A of our Annual Report on Form 10-K for the fiscal year ended August 31, 2022. We did not utilize any foreign currency or interest rate derivative instruments during the quarter ended November 30, 2022.

ITEM 4. CONTROLS AND PROCEDURES

**Evaluation of Disclosure Controls and Procedures**

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company's Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

------

We evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, as of the end of the period covered by this report. Based on this evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

There were no changes in our internal controls over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f)) during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

‎

------

PART II. OTHER INFORMATION

Item 1A. RISK FACTORS

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K as filed with the SEC on November 14, 2022.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table summarizes the purchases of our common stock during the fiscal quarter ended November 30, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs<sup>(1)</sup><br>(in thousands) |
| September 1, 2022 to September 30, 2022 | - | $- | - | $19510 |
| October 1, 2022 to October 31, 2022 | - | $- | - | $19510 |
| November 1, 2022 to November 30, 2022 | - | $- | - | $19510 |
| Total Common Shares | - | $- | - |  |

---

<sup>(1)</sup> On November 15, 2019, our Board of Directors approved a new plan to repurchase up to $40.0 million of our outstanding common stock. The previously existing common stock repurchase plan was canceled and the new common share repurchase plan does not have an expiration date. The actual timing, number, and value of common shares repurchased under our board-approved plan will be determined at our discretion and will depend on a number of factors, including, among others, general market and business conditions, the trading price of common shares, and applicable legal requirements. We have no obligation to repurchase any common shares under the authorization, and the repurchase plan may be suspended, discontinued, or modified at any time for any reason.

The table above excludes 17,639 shares of our common stock that were withheld for statutory taxes on shares distributed to participants in stock-based compensation plans during the quarter ended November 30, 2022. The withheld shares were valued at the market price on the date that the shares were distributed to participants and were acquired at a weighted average price of $47.37 per share.

Item 6. EXHIBITS

(A)Exhibits:

---

| | |
|:---|:---|
| [<u>31.1</u>](fc-20221130xex31_1.htm) | [<u>Rule 13a-14(a) Certifications of the Chief Executive Officer.\*\*</u>](fc-20221130xex31_1.htm) |
| [<u>31.2</u>](fc-20221130xex31_2.htm) | [<u>Rule 13a-14(a) Certifications of the Chief Financial Officer.\*\*</u>](fc-20221130xex31_2.htm) |
| [<u>32</u>](fc-20221130xex32.htm) | [<u>Section 1350 Certifications.\*\*</u>](fc-20221130xex32.htm) |
| 101.INS | XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.\*\* |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.\*\* |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.\*\* |
| 101.DEF | Inline XBRL Taxonomy Definition Linkbase Document.\*\* |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.\*\* |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.\*\* |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\*\* |
| \*\* | Filed herewith. |

---

------

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | FRANKLIN COVEY CO. | FRANKLIN COVEY CO. |
| Date: January 9, 2023 | By: | /s/ Paul S. Walker |
|  |  | Paul S. Walker |
|  |  | President and Chief Executive Officer |
|  |  | (Duly Authorized Officer) |
| Date: January 9, 2023 | By: | /s/ Stephen D. Young |
|  |  | Stephen D. Young |
|  |  | Chief Financial Officer |
|  |  | (Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**SECTION 302 CERTIFICATION**

I, Paul S. Walker, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1. I have reviewed this quarterly report on Form 10-Q of Franklin Covey Co.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: January 9, 2023 | /s/ Paul S. Walker |
|  | Paul S. Walker |
|  | Chief Executive Officer |

---

------

## Exhibit 31.2

**Exhibit 31.2**

**SECTION 302 CERTIFICATION**

I, Stephen D. Young, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1. I have reviewed this quarterly report on Form 10-Q of Franklin Covey Co.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: January 9, 2023 | /s/ Stephen D. Young |
|  | Stephen D. Young |
|  | Chief Financial Officer |

---

------

## Ex-32

**Exhibit 32**

**CERTIFICATION**

In connection with the quarterly report of Franklin Covey Co. (the "Company") on Form 10-Q for the period ended November 30, 2022, as filed with the Securities and Exchange Commission (the "Report"), we, Paul S. Walker, President and Chief Executive Officer of the Company, and Stephen D. Young, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of our knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, "filed" with the Securities and Exchange Commission.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;/s/ Paul S. Walker | &nbsp;&nbsp;&nbsp;&nbsp;/s/ Stephen D. Young |
| Paul S. Walker<br>Chief Executive Officer | Stephen D. Young<br>Chief Financial Officer |
| Date: January 9, 2023 | Date: January 9, 2023 |

---

------